A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo
- 1 March 2007
- Vol. 131 (3), 682-689
- https://doi.org/10.1378/chest.06-1696
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Epidemiology and costs of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006
- The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health actionGlobalization and Health, 2005
- Burden and clinical features of chronic obstructive pulmonary disease (COPD)The Lancet, 2004
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysisThorax, 2003
- Long-Term Effects of Inhaled Corticosteroids on FEV1 in Patients with Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 2003
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Inhaled Corticosteroids Are Beneficial in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994